Tradename: FLOMAX

A Study Assessing a Range of Formulations of the Fixed Dose Combination Product Containing Dutasteride (0.5mg) and Tamsulosin Hydrochloride (0.2mg) to Find a Formulation Which is Bioequivalent to Harnal-D Tablets (Tamsulosin Hydrochloride, 0.2mg) in Healthy Male Subjects From North East Asia
Status: Completed Condition: Prostatic Hyperplasia

A Study to Determine the Bioavailability of a Fixed Dose Combination Product of Dutasteride (0.5mg) and Tamsulosin Hydrochloride (0.2mg) Relative to Co-administration of the Individual Components in Healthy Male Subjects of North East Asian and Non-Asian Ancestry.
Status: Completed Condition: Prostatic Hyperplasia

Bioavailability of Two Combination Products of Dutasteride (0.5mg) and Tamsulosin Hydrochloride (0.2mg) in Asian Males.
Status: Completed Condition: Prostatic Hyperplasia

Clinical Effect and Safety of Tamsulosin 0.4mg in Patients With LUTS/BPH Refractory to Tamsulosin 0.2mg
Status: Active, not recruiting Condition: Benign Prostatic Hyperplasia

Efficacy of Flomax to Improve Stone Passage Following Shock Wave Lithotripsy
Status: Terminated Condition: Urolithiasis

Efficacy and Safety Study of Dutasteride and Tamsulosin Followed by Counseling on Flexible Dosing of Tamsulosin on as Needed Basis, to Treat Benign Prostatic Hyperplasia (BPH)
Status: Completed Condition: Benign Prostatic Hyperplasia

The Efficacy of Tamsulosin in the Treatment of Ureteral Stones in Emergency Department Patients
Status: Completed Condition: Kidney Stones; Ureteral Stones

Tamsulosin Hydrochloride 0.4 mg Capsules Under Fed Conditions
Status: Completed Condition: Healthy

A Study With Combination Treatment (Tamsulosin Hydrochloride and Solifenacin Succinate) in Male Patients With LUTS/BPH
Status: Completed Condition: Lower Urinary Tract Symptoms; Prostatic Hyperplasia

Tamsulosin Hydrochloride 0.4 mg Capsules Under Fasting Conditions
Status: Completed Condition: Healthy